Published annually, volumes in this series provide readers with
updates of clinical trial results, impacts of trials on guidelines
and evidence-based practice, advances in trial methodologies, and
the evolution of biomarkers in trials. The series focuses on trials
in neurotherapeutics, including disease-modifying and symptomatic
agents for neurological diseases, psychopharmacological management
of neurologic and psychiatric illnesses, and non-drug treatments.
Each paper is authored by a leader in the area of neurotherapeutics
and clinical trials, and the series is guided by an editor-in-chief
and editorial board with broad experience in drug development and
neuropsychopharmacology. Progress in Neurotherapeutics and
Neuropsychopharmacology is an essential update of trials in all
aspects of the management of neurologic and neuropsychiatric
disorders, and will be an invaluable resource for practising
neurologists as well as clinical and translational neuroscientists.
This volume was first published in 2006.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!